Eldecalcitol (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Eldecalcitol (Standard)
Description:
Eldecalcitol (Standard) is the analytical standard of Eldecalcitol. This product is intended for research and analytical applications. Eldecalcitol (ED-71) is an orally active vitamin D3 analogue, inhibits bone resorption and increases bone mineral density. Eldecalcitol (ED-71) displays anti-tumor effect and inhibits cell proliferation, migration and induces apoptosis by suppressing GPx-1[1][2][3][4].Product Name Alternative:
ED-71 (Standard) ; 2- (3-hydroxypropoxy) -1,25-dihydroxyvitamin D3 (Standard)UNSPSC:
12352211Target:
Apoptosis; Reference Standards; VD/VDRType:
Reference StandardsRelated Pathways:
Apoptosis; Others; Vitamin D Related/Nuclear ReceptorField of Research:
Cancer; Metabolic Disease; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/eldecalcitol-standard.htmlSmiles:
O[C@H]1[C@@H](OCCCO)[C@H](O)C(/C(C1)=C\C=C2[C@]3([H])CC[C@H]([C@H](C)CCCC(C)(O)C)[C@@]3(C)CCC\2)=CMolecular Formula:
C30H50O5Molecular Weight:
490.72References & Citations:
[1]Matsumoto T.Osteoporosis Treatment by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan.Curr Osteoporos Rep. 2012 Aug 24.|[2]Huang C, et al. Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway. Drug Des Devel Ther. 2020 Nov 13;14:4901-4913.|[3]Lu Y, et al. Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx-1. Oral Dis. 2021 Aug 24. |[4]Saito H, et al. Eldecalcitol and calcitriol stimulates 'bone minimodeling, ' focal bone formation without prior bone resorption, in rat trabecular bone. J Steroid Biochem Mol Biol. 2013 Jul;136:178-82.Shipping Conditions:
Room temperatureScientific Category:
Reference StandardsCAS Number:
[104121-92-8]
